Your browser doesn't support javascript.
loading
CRISPR single base-editing: in silico predictions to variant clonal cell lines.
Dickson, Kristie-Ann; Field, Natisha; Blackman, Tiane; Ma, Yue; Xie, Tao; Kurangil, Ecem; Idrees, Sobia; Rathnayake, Senani N H; Mahbub, Rashad M; Faiz, Alen; Marsh, Deborah J.
Afiliación
  • Dickson KA; Translational Oncology Group, Faculty of Science, School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Field N; Translational Oncology Group, Faculty of Science, School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Blackman T; Translational Oncology Group, Faculty of Science, School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Ma Y; Translational Oncology Group, Faculty of Science, School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Xie T; Translational Oncology Group, Faculty of Science, School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Kurangil E; Translational Oncology Group, Faculty of Science, School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Idrees S; Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute and the University of Technology Sydney, Sydney, NSW 2007, Australia.
  • Rathnayake SNH; Respiratory Bioinformatics and Molecular Biology (RBMB), Faculty of Science, School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Mahbub RM; Respiratory Bioinformatics and Molecular Biology (RBMB), Faculty of Science, School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Faiz A; Respiratory Bioinformatics and Molecular Biology (RBMB), Faculty of Science, School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Marsh DJ; Translational Oncology Group, Faculty of Science, School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia.
Hum Mol Genet ; 32(17): 2704-2716, 2023 08 26.
Article en En | MEDLINE | ID: mdl-37369005
ABSTRACT
Engineering single base edits using CRISPR technology including specific deaminases and single-guide RNA (sgRNA) is a rapidly evolving field. Different types of base edits can be constructed, with cytidine base editors (CBEs) facilitating transition of C-to-T variants, adenine base editors (ABEs) enabling transition of A-to-G variants, C-to-G transversion base editors (CGBEs) and recently adenine transversion editors (AYBE) that create A-to-C and A-to-T variants. The base-editing machine learning algorithm BE-Hive predicts which sgRNA and base editor combinations have the strongest likelihood of achieving desired base edits. We have used BE-Hive and TP53 mutation data from The Cancer Genome Atlas (TCGA) ovarian cancer cohort to predict which mutations can be engineered, or reverted to wild-type (WT) sequence, using CBEs, ABEs or CGBEs. We have developed and automated a ranking system to assist in selecting optimally designed sgRNA that considers the presence of a suitable protospacer adjacent motif (PAM), the frequency of predicted bystander edits, editing efficiency and target base change. We have generated single constructs containing ABE or CBE editing machinery, an sgRNA cloning backbone and an enhanced green fluorescent protein tag (EGFP), removing the need for co-transfection of multiple plasmids. We have tested our ranking system and new plasmid constructs to engineer the p53 mutants Y220C, R282W and R248Q into WT p53 cells and shown that these mutants cannot activate four p53 target genes, mimicking the behaviour of endogenous p53 mutations. This field will continue to rapidly progress, requiring new strategies such as we propose to ensure desired base-editing outcomes.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistemas CRISPR-Cas / Edición Génica Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Hum Mol Genet Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistemas CRISPR-Cas / Edición Génica Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Hum Mol Genet Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Año: 2023 Tipo del documento: Article País de afiliación: Australia